CytoMed Therapeutics logo

CytoMed Therapeutics

GDTC | NASDAQ
Chart Builder DCF Calculator
$0.77
-$0.06 (-7.15%)
At close: Nov 16, 2026, 4:00 PM ET
$0.77
$0.00 (+0.51%)
After-hours: Nov 16, 2026, 4:00 PM ET
-7.15%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
23
+4.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #965/1021 (Top 95%)

Key Statistics

Market Data

Market Cap $9.16M
1D Range
0.76 0.85
52W Range
0.72 1.98

Valuation (TTM)

PE -2.25
PB 2.38
EV/EBITDA -2.24

Valuation (NTM)

Forward PE N/A
Forward PEG -0.30
Price Target $0.00
Loading financial charts...

Profile

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunother...

Sector Healthcare
Industry Biotechnology
Employees 42
IPO Date Apr 14, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.